艾弗梅克:一种治疗策略,用于治疗耐性患者
Diana Carolina Ortega1, Luis Prieto-Valiente2, Arnold H Zea3
1Neurology Outpatient, Neurological Care Center 'Neurólogos de Occidente', Cali, Colombia.
伊弗梅克丁 (IVM) 显示出作为药物耐药性的辅助疗法的显著前景. 现实世界的数据显示,耐药性患者的发作显著减少,耐受性改善.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐药性 (DRE) 影响了相当一部分患者,构成了重大的临床挑战.
- 目前的多疗法往往无法在多达三分之一的DRE患者中控制发作.
- 以其多样性的特性而闻名的IVM正在作为一种新的辅助治疗方法进行探索.
研究的目的:
- 评估艾弗梅克丁 (IVM) 作为高度耐火性患者的辅助疗法的疗效和安全性.
- 评估IVM启动后的发作频率,发作控制和同时服用抗药物 (ASM) 负担的变化.
主要方法:
- 一项观察性研究涉及146名患有高度耐火性的患者,他们与标准ASM一起接受IVM.
- 通过患者日记,发作频率被仔细记录下来,使用国际抗联盟标准评估了发作控制.
- IVM是口服的,每周的剂量从30毫克到280毫克不等.
主要成果:
- 在IVM治疗后,观察到每年发作频率的显著平均减少88.9%.
- 超过90%的参与者实现了发作自由,所有患者报告了一些发作减少.
- 同时的ASM负担下降了22%,耐受性良好,没有重大安全问题.
结论:
- 伊弗梅克丁 (IVM) 显示出作为一种有效且耐受性良好的辅助疗法的巨大潜力,用于治疗耐药性.
- 这些发现支持IVM的抗发作作用,可能通过调节神经元刺激性和神经炎症通路.
- 进一步的随机对照试验是有必要的,以确定最佳的IVM剂量,安全性概况和管理的机制基础.
更多相关视频
05:33A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Electroconvulsive Therapy
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
